Benzinga | Jun 4, 2021 07:33AM EDT

Zynerba Highlights Poster Presentation At Associated Professional Sleep Societies SLEEP 2021 Annual Meeting Jun. 11

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the acceptance and presentation details of a poster at SLEEP 2021, the 35th Annual Meeting of the Associated Professional Sleep Societies, LLC, which will be held virtually from June 10-13, 2021. A copy of the poster will be made available on the Zynerba corporate website at the time of presentation at http://zynerba.com/publications/. Additional meeting information can be found on the SLEEP website at https://www.sleepmeeting.org/.

Poster presentation details

Impact of ZYN002 Cannabidiol Transdermal Gel on Sleep in Children andTitle Adolescents with Developmental and Epileptic Encephalopathies and Comorbid Autism Spectrum DisorderSession Late-Breaking AbstractsDate June 11, 2021Time Starting at 12:15 p.m. ET